ABSTRACT Objective The Gold Coast criteria permit diagnosis of amyotrophic lateral sclerosis (ALS) even without upper motor neuron (UMN) signs. However, whether ALS patients with UMN signs (ALSwUMN) and those without (ALSwoUMN) share similar characteristics and prognoses remains unclear.
Hee‐Jae Jung +7 more
wiley +1 more source
CircHOMER1 in mediating porcine skeletal muscle development. [PDF]
Li M +8 more
europepmc +1 more source
Development of an Impact Experimental System for Injury Evaluation of Skeletal Muscle
Sota YAMAMOTO +6 more
openalex +1 more source
Cutaneous Phosphorylated Alpha‐Synuclein in Lewy Body Dementia
ABSTRACT Objective To determine the test performance of cutaneous phosphorylated alpha‐synuclein (P‐SYN) in dementia with Lewy bodies (DLB), individuals with reduced Montreal Cognitive Assessment (MoCA) and healthy controls. Methods This is the first subgroup analysis of the Synuclein‐One study, a prospective, blinded study evaluating P‐SYN detection ...
Christopher H. Gibbons +31 more
wiley +1 more source
Transcriptome Dynamics and Regulatory Networks of Postnatal Muscle Development in Leizhou Black Goats. [PDF]
Han J +5 more
europepmc +1 more source
Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein +13 more
wiley +1 more source
Molecular Characterization and Functional Insights into Goose IGF2BP2 During Skeletal Muscle Development. [PDF]
Wang C, Liu Y, Dai J, Chen S, He D.
europepmc +1 more source
FGF5 stimulates expansion of connective tissue fibroblasts and inhibits skeletal muscle development in the limb [PDF]
Kari Clase +5 more
openalex +1 more source
Neuropsychiatric Symptoms Mimicking Dementia in a Patient Treated With Imatinib
ABSTRACT Tyrosine kinase inhibitors are the cornerstone of chronic myeloid leukemia treatment. Newer agents have more potency and a broader spectrum of action, but also a higher potential for neuropsychiatric side effects. We present a case of a patient on imatinib who developed progressive cognitive, mood, and behavioral alterations.
Ashley Jones +3 more
wiley +1 more source
Recent advances in the role of CARM1 in skeletal muscle development, metabolism, and homeostasis maintenance. [PDF]
Xie X, Li M, Zhang Y, Bao Z, Yi X.
europepmc +1 more source

